Literature DB >> 12472302

The impact of childhood psychopathology interventions on subsequent substance abuse: policy implications, comments, and recommendations.

Philip C Kendall1, Ronald C Kessler.   

Abstract

This article makes observations about policy implications and offers a combination of commentary and recommendation regarding the special issue on the impact of childhood psychopathology interventions on subsequent substance abuse. The authors mention forward-looking directives to expand the mandate for early intervention, to expand the research agenda for randomized clinical trials, and to develop a policy-oriented evidence base. They also note topics that require consideration and offer recommendations with regard to how to proceed. The special issue, as well as this discussion, will spark thought and action directed toward the evaluation of interventions for youths to assess the degree to which treating mental disorders has beneficial effects on the sequelae of the initial intervention target.

Entities:  

Mesh:

Year:  2002        PMID: 12472302

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  23 in total

1.  Cognitive-behavioral therapy for child anxiety confers long-term protection from suicidality.

Authors:  Courtney Benjamin Wolk; Philip C Kendall; Rinad S Beidas
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-12-17       Impact factor: 8.829

Review 2.  The complex role of sleep in adolescent depression.

Authors:  Greg Clarke; Allison G Harvey
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2012-04

3.  CBT for childhood anxiety and substance use at 7.4-year follow-up: a reassessment controlling for known predictors.

Authors:  Connor Morrow Puleo; Bradley T Conner; Courtney L Benjamin; Philip C Kendall
Journal:  J Anxiety Disord       Date:  2011-03-15

4.  Recovery and recurrence following treatment for adolescent major depression.

Authors:  John Curry; Susan Silva; Paul Rohde; Golda Ginsburg; Christopher Kratochvil; Anne Simons; Jerry Kirchner; Diane May; Betsy Kennard; Taryn Mayes; Norah Feeny; Anne Marie Albano; Sarah Lavanier; Mark Reinecke; Rachel Jacobs; Emily Becker-Weidman; Elizabeth Weller; Graham Emslie; John Walkup; Elizabeth Kastelic; Barbara Burns; Karen Wells; John March
Journal:  Arch Gen Psychiatry       Date:  2010-11-01

5.  Self-reported Barriers to Treatment Engagement: Adolescent Perspectives from the National Comorbidity Survey-Adolescent Supplement (NCS-A).

Authors:  Amy Sylwestrzak; Chelsea E Overholt; Kelly I Ristau; Kendell L Coker
Journal:  Community Ment Health J       Date:  2014-10-19

6.  Inpatient care in Serbia: trends in hospitalization and diagnostics over time.

Authors:  Milica Pejovic-Milovancevic; Ana Kesic; Roberto Grujicic; Ana Stojkovic; Sanja Zivotic; Dusan Stupar; Vladimir Borovnica; Jelena Radosavljev-Kircanski; Iva Manojlovic; Dragan J Stojiljkovic
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-12       Impact factor: 4.785

7.  Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits.

Authors:  M D Glantz; J C Anthony; P A Berglund; L Degenhardt; L Dierker; A Kalaydjian; K R Merikangas; A M Ruscio; J Swendsen; R C Kessler
Journal:  Psychol Med       Date:  2008-12-02       Impact factor: 7.723

8.  Using electronic health records data to assess comorbidities of substance use and psychiatric diagnoses and treatment settings among adults.

Authors:  Li-Tzy Wu; Kenneth R Gersing; Marvin S Swartz; Bruce Burchett; Ting-Kai Li; Dan G Blazer
Journal:  J Psychiatr Res       Date:  2013-01-19       Impact factor: 4.791

9.  Anxiety and related outcomes in young adults 7 to 19 years after receiving treatment for child anxiety.

Authors:  Courtney L Benjamin; Julie P Harrison; Cara A Settipani; Douglas M Brodman; Philip C Kendall
Journal:  J Consult Clin Psychol       Date:  2013-05-20

10.  Psychopathology risk transmission in children of parents with substance use disorders.

Authors:  Duncan B Clark; Jack Cornelius; D Scott Wood; Michael Vanyukov
Journal:  Am J Psychiatry       Date:  2004-04       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.